Literature DB >> 16409903

A review of the effect of occlusive dressings on lamellar bodies in the stratum corneum and relevance to transdermal absorption.

Lauren Kennish1, Bruce Reidenberg.   

Abstract

Transdermal drug delivery is becoming a widely used tool in the pharmaceutical industry. Many factors can influence the transdermal flux of medication from a transdermal drug delivery system. The recently described skin physiology of lamellar bodies and skin responses to occlusive dressings provide new insights into transdermal drug delivery. This paper reviews the literature on occlusive dressings and lamellar bodies as it relates to transdermal drug delivery. An understanding of the physiology of lamellar bodies is important to understand and improve transdermal drug delivery.

Mesh:

Year:  2005        PMID: 16409903

Source DB:  PubMed          Journal:  Dermatol Online J        ISSN: 1087-2108


  5 in total

1.  Formation and closure of microchannels in skin following microporation.

Authors:  Haripriya Kalluri; Ajay K Banga
Journal:  Pharm Res       Date:  2010-03-31       Impact factor: 4.200

2.  Characterization of microchannels created by metal microneedles: formation and closure.

Authors:  Haripriya Kalluri; Chandra Sekhar Kolli; Ajay K Banga
Journal:  AAPS J       Date:  2011-07-06       Impact factor: 4.009

Review 3.  Current aspects of formulation efforts and pore lifetime related to microneedle treatment of skin.

Authors:  Mikolaj Milewski; Nicole K Brogden; Audra L Stinchcomb
Journal:  Expert Opin Drug Deliv       Date:  2010-05       Impact factor: 6.648

4.  In vitro permeation of micronized and nanonized alaptide from semisolid formulations.

Authors:  Radka Opatrilova; Aneta Cernikova; Lenka Coufalova; Jiri Dohnal; Josef Jampilek
Journal:  ScientificWorldJournal       Date:  2013-12-18

5.  In Situ Gel Formation in Microporated Skin for Enhanced Topical Delivery of Niacinamide.

Authors:  Sonalika Bhattaccharjee; Moritz Beck-Broichsitter; Ajay K Banga
Journal:  Pharmaceutics       Date:  2020-05-21       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.